Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (375 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 01 Mar 2024 – 20 Aug 2026, limited by Groww Nifty Smallcap 250 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Groww Nifty Smallcap 250 Index Fund | Nifty Smallcap 250 |
|---|---|---|
| 01 Mar 2024 | ₹100.00 | ₹100.00 |
| 15 May 2024 | ₹102.14 | ₹102.46 |
| 29 Jul 2024 | ₹118.06 | ₹118.43 |
| 13 Oct 2024 | ₹120.53 | ₹120.93 |
| 27 Dec 2024 | ₹117.21 | ₹117.62 |
| 12 Mar 2025 | ₹93.85 | ₹94.24 |
| 26 May 2025 | ₹109.88 | ₹110.34 |
| 09 Aug 2025 | ₹109.54 | ₹109.83 |
| 23 Oct 2025 | ₹114.13 | ₹114.50 |
| 07 Jan 2026 | ₹111.44 | ₹111.65 |
| 23 Mar 2026 | ₹94.26 | ₹94.50 |
| 06 Jun 2026 | ₹113.04 | ₹113.23 |
| 20 Aug 2026 | ₹121.74 | ₹121.76 |
| Metric | Groww · Direct NAV ₹12.25 Very High risk ★★★☆☆ 1Y | Category median Index Funds · 375 funds |
|---|---|---|
| +7.71% | +5.66% | |
| — | +8.82% | |
| — | +9.15% | |
| — | +11.72% | |
| +8.29% | +7.67% | |
| +8.83% | — | |
| — | +12.67% | |
| — | +13.64% | |
| — | +12.84% | |
| Risk | ||
| 19.84% | 13.97% | |
| 0.06 | 0.24 | |
| 0.08 | 0.36 | |
| -26.23% | -16.12% | |
| Nifty Smallcap 250 | — | |
| — | +0.84% | |
| — | 1.00 | |
| — | 102.2% | |
| — | 97.2% | |
| 0.59% | 0.36% | |
| ₹125.62Cr | ₹177.09Cr | |
| 0.25% | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| 23% | 35% | |
| Nikhil Satam | — | |
| 01 Mar 2024 | — | |
| 250 | — | |
| 11.6% | — | |
| -0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.